查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088622

胃內球囊市場：2026-2032年全球市場預測（依產品類型、填充材、手術方式、留置時間及應用分類）

Intragastric Balloon Market by Product Type, Filling Material, Procedure Type, Duration of Implantation, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胃內球囊市場將成長至 4,175 萬美元，複合年成長率為 8.56%。

主要市場統計數據
基準年 2025 2349萬美元
預計年份：2026年 2924萬美元
預測年份 2032 4175萬美元
複合年成長率 (%) 8.56%

胃內球囊肥胖治療醫療器械，植入胃部後可產生飽腹感，幫助控制食物攝入，並在醫生醫療設備下幫助患者減輕減重，且不會造成永久性解剖結構改變。其市場需求源自於已證實的公共衛生需求。根據世界衛生組織（WHO）統計，2022年全球超過25億成年人超重，其中超過8.9億人肥胖。

胃內球囊市場介於生活型態療法和減重手術之間，主要針對那些僅靠飲食和運動無法達到理想效果，但又不適合手術或可能正在延後手術的患者。市場發展動能取決於循證的患者篩選、內視鏡檢查系統、明確的保險報銷政策、術後營養管理方案以及對已知器械風險的嚴格控制。

胃內球囊領域的變革性變化

胃內球囊領域正從單純依賴減重轉向綜合肥胖治療。由於球囊治療是一種暫時性治療，需要系統性的生活方式支持才能達到持久療效，因此醫療服務提供者擴大將球囊植入與營養指導、行為輔導、後續觀察監測和數位追蹤相結合，以提高球囊取出後的治療依從性。

人工智慧對胃內球囊的累積影響

人工智慧 (AI) 正逐漸成為胃內胃內球囊整個價值鏈中一股切實的驅動力。 AI 輔助篩檢使臨床醫生能夠評估身體質量指數 (BMI)、共病、手術史、用藥情況、營養風險和禁忌症等因素。此外，其分析能力還能辨識出植入後可能需要更詳細的營養和行為支持的患者。

主要胃內球囊市場的關鍵區域洞察

北美憑藉其完善的內視鏡基礎設施、獲得FDA已通過核准的球囊擴張系統、專業的肥胖症診療以及較高的肥胖症盛行率，仍然是肥胖症治療的主要中心。根據美國疾病管制與預防中心（CDC）的報告，2021年8月至2023年8月，美國成人肥胖率高達40.3%。歐洲受益於肥胖症治療中心的設立、臨床指引的採納以及歐盟醫療設備法規的完善。同時，亞太地區正經歷市場擴張，這得益於私立醫院的成長、代謝性疾病負擔的加重、主要經濟體先進的內視鏡技術以及部分國家醫療旅遊業的蓬勃發展。

關於引入胃內球囊的關鍵群體分析

在整個歐盟範圍內，統一的醫療設備法規和基於GDPR的資料標準正在影響產品的可近性、上市後監測、臨床文件和數位化追蹤模式。七國集團（G7）國家擁有先進的臨床基礎設施、專業的肥胖症治療項目和研究能力，而北約成員國中也包括許多高所得國家，這些國家的醫療保健系統優先考慮安全報告、採購彈性以及醫療設備供應的連續性。

各國對胃內球囊成長情況的洞察

美國在受監管的商業活動方面處於主導地位，這得益於FDA對醫療設備、肥胖症治療網路和門診內視鏡服務的監管。在加拿大，重點在於專科轉診、省級醫療服務覆蓋範圍和安全監管。墨西哥和巴西受益於成熟的肥胖症治療社區、都市區私人醫療保健系統以及自費需求。在歐洲，英國、德國、法國、義大利和西班牙將內視鏡服務與系統化的肥胖症治療服務和臨床管治結合。在俄羅斯，醫療服務的可近性預計將受到當地法規、購買力和專科醫生數量的影響。

為胃內球囊行業的領導者提供的實用建議

產業領導者應將胃內球囊定位為綜合肥胖治療方案的一部分，而非單一的手術。差異化優勢應體現在已證實的減重效果、不利事件的透明度、結構化的營養方案、患者教育以及球囊取出和維持階段的患者持續參與等方面。

胃內球囊分析的調查方法

本執行摘要是基於對已核實的公共來源的二手研究，包括世界衛生組織 (WHO)、美國疾病管制與預防中心 (CDC) 和美國食品藥物管理局(FDA) 發布的有關醫療設備的公告、同行檢驗的肥胖相關文獻、臨床實踐指南以及公開的監管資訊來源。

結論：胃內球囊的策略性展望

隨著肥胖症治療領域向以結果為導向的多學科交叉模式轉變，胃內球囊市場也不斷發展。強烈的公共衛生需求、微創手術的優勢以及與系統性生活方式乾預計畫的協同效應，持續支撐著市場需求，尤其是在內鏡基礎設施完善、肥胖症治療團隊訓練有素的地區。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：胃內球囊市場：依產品類型分類

  • 單球囊系統
  • 多球囊系統
  • 無需手術的球囊

第8章：胃內球囊市場：依填充材

  • 充滿生理食鹽水的氣球
  • 充氣氣球

第9章：胃內球囊市場：依手術類型分類

  • 內視鏡置入
  • 非內視鏡放置

第10章：胃內球囊市場：依留置時間分類

  • 不到3個月
  • 3-6個月
  • 超過6個月

第11章：胃內球囊市場：依應用領域分類

  • 減重
  • 減重手術前的減重
  • 術後體重維持
  • 代謝性疾病的管理

第12章：胃內球囊市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：胃內球囊市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：胃內球囊市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Allurion Technologies, Inc.
  • Apollo Endosurgery, Inc.
  • Bariatric Solutions Ltd.
  • Baronova, Inc.
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Endalis SAS
  • EndoSphere Srl
  • Helioscopie Medical Implants
  • Johnson & Johnson
  • Medicone GmbH
  • Medispar NV
  • Medsil
  • Medtronic plc
  • Obalon Therapeutics, Inc.
  • Silimed Industria de Implantes Ltda.
  • Spatz FGIA, Inc.
  • Suzhou Shenyun Medical Equipment Co., Ltd.
Product Code: MRR-7C5681F8681E

The Intragastric Balloon Market is projected to grow by USD 41.75 million at a CAGR of 8.56% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 23.49 million
Estimated Year [2026] USD 29.24 million
Forecast Year [2032] USD 41.75 million
CAGR (%) 8.56%

Intragastric balloons are minimally invasive obesity treatment devices placed in the stomach to create satiety, support portion control, and help patients achieve medically supervised weight loss without permanent anatomical alteration. Demand is anchored in a documented public health need: the World Health Organization reported that more than 2.5 billion adults were overweight in 2022, including over 890 million adults living with obesity.

The intragastric balloon market is positioned between lifestyle therapy and bariatric surgery, serving patients who need more than diet and exercise but may not qualify for, or may defer, surgical procedures. Commercial momentum depends on evidence-based patient selection, endoscopic capacity, reimbursement clarity, post-placement nutrition programs, and rigorous management of known device risks.

Transformative Shifts in the Intragastric Balloon Landscape

The intragastric balloon landscape is shifting from device-only weight loss toward integrated obesity care. Providers increasingly combine balloon placement with dietetics, behavioral coaching, metabolic monitoring, and digital follow-up to improve adherence after removal, since balloons are temporary therapies and durable outcomes require structured lifestyle support.

Competition is also being reshaped by pharmacotherapy, especially GLP-1 receptor agonists and dual incretin medicines, which have raised expectations for clinically meaningful weight loss. Rather than replacing intragastric balloons outright, these therapies are encouraging hybrid care pathways where balloons, medications, and bariatric procedures are matched to patient risk, affordability, contraindications, and treatment goals.

Cumulative Impact of Artificial Intelligence on Intragastric Balloons

Artificial intelligence is becoming a practical enabler across the intragastric balloon value chain. AI-supported screening can help clinicians evaluate BMI, comorbidities, prior procedures, medication use, nutritional risk, and contraindications, while analytics can flag patients who may need closer nutritional or behavioral support after placement.

AI also supports operational efficiency through automated scheduling, adverse-event surveillance, documentation review, coding support, and remote patient engagement. Its impact remains cumulative rather than standalone: AI does not replace clinical judgment or regulatory compliance, but it can improve consistency, patient retention, and real-world evidence generation when deployed under privacy, cybersecurity, and medical-device governance.

Key Regional Insights Across Major Intragastric Balloon Markets

North America remains a key adoption center because of established endoscopy infrastructure, FDA-cleared balloon systems, obesity-focused specialty care, and high disease prevalence; the CDC reported U.S. adult obesity at 40.3% for August 2021-August 2023. Europe benefits from specialist obesity centers, clinical guideline adoption, and EU medical-device oversight, while Asia-Pacific is expanding through private hospitals, rising metabolic disease burden, advanced endoscopy capabilities in major economies, and growing medical tourism in selected countries.

Latin America shows opportunity where self-pay obesity care and bariatric expertise are strong, especially in urban centers across Brazil and Mexico. The Middle East is supported by high diabetes and obesity awareness in Gulf markets and public health strategies that emphasize prevention and weight management, while Africa remains earlier-stage, with demand concentrated in private hospitals and constrained by affordability, trained specialists, endoscopy availability, and long-term follow-up capacity.

Key Group Insights for Intragastric Balloon Adoption

Across the European Union, harmonized medical-device rules and GDPR-driven data standards influence product access, post-market surveillance, clinical documentation, and digital follow-up models. G7 markets offer advanced clinical infrastructure, specialist obesity programs, and research capacity, while NATO countries overlap with many high-income health systems that prioritize safety reporting, procurement resilience, and continuity of medical-device supply.

ASEAN growth is tied to private care, urban obesity trends, rising noncommunicable disease awareness, and cross-border medical services in major hubs. GCC countries show strong potential due to obesity and diabetes prevention priorities, high specialist-care investment, and demand for minimally invasive weight-loss options. BRICS markets add scale through large patient populations and expanding healthcare access, but pricing, physician training, regulatory pathways, and reimbursement variability determine how quickly intragastric balloons move beyond premium self-pay segments.

Key Country Insights for Intragastric Balloon Growth

The United States leads in regulated commercial activity, supported by FDA device oversight, obesity medicine networks, and ambulatory endoscopy capacity, while Canada emphasizes specialist referral, provincial access dynamics, and safety oversight. Mexico and Brazil benefit from established bariatric communities, urban private healthcare capacity, and self-pay demand. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine endoscopy capacity with structured obesity services and clinical governance, while Russia presents access potential shaped by local regulation, purchasing power, and specialist availability.

China and India represent large long-term opportunities because of rising obesity, diabetes, and cardiometabolic risk burdens, though affordability, patient awareness, procedure access, and provider training remain decisive. Japan and South Korea bring advanced endoscopy capabilities, quality-focused adoption, and high procedural standards, while Australia supports medically supervised weight management through private hospitals, specialist clinic networks, and multidisciplinary obesity care pathways.

Actionable Recommendations for Intragastric Balloon Industry Leaders

Industry leaders should position intragastric balloons as part of a full obesity-care pathway rather than a stand-alone procedure. Differentiation should focus on documented weight-loss outcomes, adverse-event transparency, structured nutrition programs, patient education, and retention through the removal and maintenance phases.

Commercial teams should prioritize physician training, center-of-excellence partnerships, payer evidence, registry participation, and digital aftercare. Manufacturers and providers should also prepare for combination pathways with anti-obesity medications, ensuring protocols address sequencing, nutritional risk, contraindications, patient adherence, device removal planning, and long-term metabolic monitoring.

Research Methodology for Intragastric Balloon Analysis

This executive summary is based on secondary research from verified public sources, including the World Health Organization, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration device communications, peer-reviewed obesity literature, clinical practice guidance, and publicly available regulatory information.

The analysis applies market triangulation across epidemiology, regulatory status, clinical workflow, provider infrastructure, regional access conditions, obesity-treatment pathways, and competitive dynamics across lifestyle therapy, pharmacotherapy, intragastric balloons, and bariatric surgery. Qualitative insights were normalized to avoid unsupported market sizing, market share, or forecasting and to maintain evidence-based interpretation for strategic decision-making.

Conclusion: Strategic Outlook for Intragastric Balloons

The intragastric balloon market is evolving within a broader shift toward multidisciplinary, outcomes-based obesity care. Strong public health need, minimally invasive delivery, and compatibility with structured lifestyle programs continue to support demand, particularly where endoscopy capacity and trained obesity teams are available.

Future performance will depend on clinical evidence, safety management, digital follow-up, and clear positioning alongside pharmacotherapy and bariatric surgery. Organizations that combine regulated devices with patient-centered support, responsible AI-enabled monitoring, and measurable outcomes are best placed to build durable competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Intragastric Balloon Market, by Product Type

  • 7.1. Single Balloon Systems
  • 7.2. Multi-balloon Systems
  • 7.3. Procedure-Free Balloons

8. Intragastric Balloon Market, by Filling Material

  • 8.1. Saline-Filled Balloons
  • 8.2. Gas-Filled Balloons

9. Intragastric Balloon Market, by Procedure Type

  • 9.1. Endoscopic Placement
  • 9.2. Non-Endoscopic Placement

10. Intragastric Balloon Market, by Duration of Implantation

  • 10.1. Less Than 3 Months
  • 10.2. 3-6 Months
  • 10.3. More Than 6 Months

11. Intragastric Balloon Market, by Application

  • 11.1. Weight Loss
  • 11.2. Pre-Bariatric Surgery Weight Reduction
  • 11.3. Post-Surgical Weight Maintenance
  • 11.4. Metabolic Disorder Management

12. Intragastric Balloon Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Intragastric Balloon Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intragastric Balloon Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Allurion Technologies, Inc.
  • 16.2. Apollo Endosurgery, Inc.
  • 16.3. Bariatric Solutions Ltd.
  • 16.4. Baronova, Inc.
  • 16.5. Boston Scientific Corporation
  • 16.6. Cook Medical LLC
  • 16.7. Endalis S.A.S.
  • 16.8. EndoSphere S.r.l.
  • 16.9. Helioscopie Medical Implants
  • 16.10. Johnson & Johnson
  • 16.11. Medicone GmbH
  • 16.12. Medispar NV
  • 16.13. Medsil
  • 16.14. Medtronic plc
  • 16.15. Obalon Therapeutics, Inc.
  • 16.16. Silimed Industria de Implantes Ltda.
  • 16.17. Spatz FGIA, Inc.
  • 16.18. Suzhou Shenyun Medical Equipment Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAGASTRIC BALLOON MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INTRAGASTRIC BALLOON MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INTRAGASTRIC BALLOON MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INTRAGASTRIC BALLOON MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAGASTRIC BALLOON MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL INTRAGASTRIC BALLOON MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE BALLOON SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE BALLOON SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE BALLOON SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MULTI-BALLOON SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MULTI-BALLOON SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MULTI-BALLOON SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROCEDURE-FREE BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROCEDURE-FREE BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROCEDURE-FREE BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SALINE-FILLED BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SALINE-FILLED BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SALINE-FILLED BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GAS-FILLED BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GAS-FILLED BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GAS-FILLED BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC PLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC PLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC PLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-ENDOSCOPIC PLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-ENDOSCOPIC PLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-ENDOSCOPIC PLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LESS THAN 3 MONTHS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LESS THAN 3 MONTHS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LESS THAN 3 MONTHS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL 3-6 MONTHS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL 3-6 MONTHS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL 3-6 MONTHS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MORE THAN 6 MONTHS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MORE THAN 6 MONTHS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MORE THAN 6 MONTHS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WEIGHT LOSS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WEIGHT LOSS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WEIGHT LOSS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PRE-BARIATRIC SURGERY WEIGHT REDUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PRE-BARIATRIC SURGERY WEIGHT REDUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PRE-BARIATRIC SURGERY WEIGHT REDUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POST-SURGICAL WEIGHT MAINTENANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POST-SURGICAL WEIGHT MAINTENANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POST-SURGICAL WEIGHT MAINTENANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL METABOLIC DISORDER MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL METABOLIC DISORDER MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL METABOLIC DISORDER MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. GCC INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 94. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 98. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. G7 INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 116. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NATO INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 122. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. CANADA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 135. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 141. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED KINGDOM INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED KINGDOM INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED KINGDOM INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED KINGDOM INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED KINGDOM INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED KINGDOM INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. GERMANY INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. GERMANY INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GERMANY INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. GERMANY INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GERMANY INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 159. GERMANY INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. FRANCE INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. FRANCE INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. FRANCE INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. FRANCE INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. FRANCE INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 165. FRANCE INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. RUSSIA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. RUSSIA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. RUSSIA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. RUSSIA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. RUSSIA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 171. RUSSIA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ITALY INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. ITALY INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ITALY INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. ITALY INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ITALY INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 177. ITALY INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. SPAIN INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. SPAIN INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. SPAIN INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. SPAIN INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. SPAIN INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 183. SPAIN INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. INDIA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. INDIA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. INDIA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. INDIA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. INDIA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 195. INDIA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. JAPAN INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. JAPAN INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. JAPAN INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. JAPAN INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. JAPAN INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 201. JAPAN INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. AUSTRALIA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. AUSTRALIA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AUSTRALIA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. AUSTRALIA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AUSTRALIA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 207. AUSTRALIA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. SOUTH KOREA INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. SOUTH KOREA INTRAGASTRIC BALLOON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. SOUTH KOREA INTRAGASTRIC BALLOON MARKET SIZE, BY FILLING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. SOUTH KOREA INTRAGASTRIC BALLOON MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. SOUTH KOREA INTRAGASTRIC BALLOON MARKET SIZE, BY DURATION OF IMPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 213. SOUTH KOREA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)